7K20-- Genomic Analysis System
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
TECHNOLOGY ACQUISITION CENTER NJ (36C10B)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C10B25Q0344
NAICS
541990 - All Other Professional, Scientific, and Technical Services
Classification Code
7K20
Additional Details
Documents2
The Technology Acquisition Center New Jersey (TAC NJ), operating under the U.S. federal government, has issued a presolicitation notice regarding the procurement of a Genomic Analysis System. This notice, identified by procurement number 36C10B25Q0344, outlines the intent to pursue a sole source acquisition strategy, with Illumina, Inc. designated as the exclusive provider for this requirement. The notice serves as an amendment to a previous Request for Information (RFI), clarifying that no further responses are required from interested parties.
The primary objective of this procurement is to acquire a Genomic Analysis System, a specialized solution likely intended to support advanced scientific and technical operations within the federal domain. While the specific technical requirements and deliverables are not detailed in the notice, the classification under NAICS code 541990 (“All Other Professional, Scientific, and Technical Services”) and Product Service Code 7K20 suggests a focus on sophisticated analytical capabilities, potentially encompassing genomic sequencing, data analysis, and related scientific services.
The contracting activity is managed by the Technology Acquisition Center NJ, a federal office responsible for sourcing advanced technology solutions. The primary point of contact for this procurement is Michael Gruen, who can be reached via email at [email protected] or by phone at 848-377-5251 for any administrative inquiries.
This procurement is classified as a sole source award, meaning that competition is not being solicited and only Illumina, Inc. will be considered for contract award. There are no set-aside requirements or special considerations for small businesses or other socioeconomic categories, as the acquisition strategy is firmly established. The notice is currently marked as inactive, indicating that the opportunity is not open for new submissions or expressions of interest.
Contractors evaluating this opportunity should note that the procurement is highly specialized and limited to a single source, with no competitive process anticipated. The scope and outcomes are centered on the deployment and support of a Genomic Analysis System, with the expectation that Illumina, Inc. will deliver all required products and services in alignment with federal scientific and technical standards.
Further details, including any attachments or supporting documents, can be accessed via the official SAM.gov opportunity listing at https://sam.gov/opp/8bed7b2c4541448aa3da8bb09017c4cd/view.